[On the characteristic peculiarities of action of cardiac glycosides during combined therapy of myocardial infarct].
D000818:Animals; D001337:Autonomic Agents / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002415:Cats; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004285:Dogs; D006168:Guinea Pigs; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001337:Autonomic Agents; D002301:Cardiac Glycosides; D000697:Central Nervous System Stimulants; D006993:Hypnotics and Sedatives; D014665:Vasodilator Agents
K kharakteristike osobennosteĭ deĭstviia serdechnykh glikozidov v usloviiakh kombinirovannoĭ terapii infarkta miokarda.